University of Angers
Also known as: Angers (FR), University College Hospital | Angers Teaching Hospital | Angers teatching hospital | Angers University Hospital | Angers University Hospital Center | Centre Hospitalier Universitaire Angers | Centre Hospitalier Universitaire (CHU) ANGERS | Centre Hospitalier Unniversitaire Angers(CHU) | Centre Paul Papin, 49933 Angers, France | Centre Paul Papin-ANGERS | Centre Paul Papin ANGERS France | Centre Régional de Coordination des Dépistages des cancers-Pays de la Loire, Angers | CHU Angers | CHU d'Angers, France | CHU of Angers | Department of Anesthesiology & Critical Care, Angers University Hospital, France | Department of Obstetrics, Angers University Hospital Center | Dept of Anesthesia, CHU, Angers - France | Memory Centre of Angers University Hospital | Universitary Hospital, Angers | Universitary hospital of Angers | UNIVERSITE HOSPITAL, ANGERS | University Angers | University Hospital, Angers | University Hospital Angers (Dept of Anesthesia) | University hospital Angers - France | University Hospital, Angers, France | University hospital of Angers
Highest phase reached
Phase 4
First clinical trial
Sep 1, 2002Last known activity
Apr 30, 2026
Timeline
1330s
- Jan 1, 1337
University of Angers— Founded
Drugs by trial phase (62 distinct, 43 trials)
Phase 4 (10 own, 0 via acquisition)
Phase 3 (23 own, 0 via acquisition)
Phase 2 (22 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (6 own, 0 via acquisition)
Indications
Studied for
- Acute Lung Injury
- Adenocarcinoma
- Alzheimer Disease
- Antiphospholipid Syndrome
- Anxiety Disorders
- Atrial Fibrillation
- Calcinosis
- Cognitive Dysfunction
- Communicable Diseases
- Congenital Abnormalities
- Conjunctivitis
- Conjunctivitis, Bacterial
- Coronavirus Infections
- Craniocerebral Trauma
- Embolism
- Enuresis
- Erectile Dysfunction
- Esophageal Neoplasms
- Fractures, Bone
- Head and Neck Neoplasms
- Hemorrhage
- Hip Fractures
- Hyperkalemia
- Infections
- Lymphangioma
- Lymphatic Abnormalities
- Mucositis
- Neoplasms
- Postpartum Hemorrhage
- Prostatic Neoplasms
- Pulmonary Embolism
- Respiratory Distress Syndrome
- Respiratory Distress Syndrome, Newborn
- Retinal Neoplasms
- Retinoblastoma
- Small Cell Lung Carcinoma
- Stomach Neoplasms
- Stomatitis
- Subarachnoid Hemorrhage
- Syndrome
- Thrombosis
- Trachoma
- Urinary Incontinence
- Vascular Calcification
- Vascular Malformations
- Venous Thrombosis
Recent trials (50)
- NCT07258667Lead sponsorPhase 1Apr 30, 2026
- NCT06892951CollaboratorPhase 1/Phase 2Jun 30, 2025
- NCT06263816CollaboratorPhase 3Nov 15, 2024
- NCT06585020CollaboratorPhase 2Oct 31, 2024
- NCT06195540OfficialPhase 3Jul 19, 2024
- NCT06195540Lead sponsorPhase 3Jul 19, 2024
- NCT06252870OfficialPhase 2Jul 18, 2024
- NCT05749276OfficialPhase 1May 31, 2024
- NCT06007391Lead sponsorPhase 2/Phase 3Sep 30, 2023
- NCT05080049Study directorPhase 3Dec 31, 2021
- NCT05080049Overall official - principal investigatorPhase 3Dec 31, 2021
- NCT05080049Lead sponsorPhase 3Dec 31, 2021
- NCT04797312Overall official - principal investigatorPhase 3Jul 12, 2021
- NCT04797312Lead sponsorPhase 3Jul 12, 2021
- NCT04344041Lead sponsorPhase 3Apr 30, 2020
Details
- Founded
- Angers, FR Jan 1, 1337
- Last known activity
- Apr 30, 2026